Home › Research › Long-term cohort studies
Liver Diseases and Brain Disorders: Genetic Mechanisms and Biomarker Pathways in a Prospective Cohort Study From the UK Biobank
Hai‐Hua Guo, Pei‐Yang Gao, Wei Zhang, Yan Fu, Hao‐Chen Chi, Zi‐Hao Zhang, Shuang‐Ling Han, Baolin Han et al.. Journal of Neurochemistry, 2025-04-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
Population-based evidence directly linking liver diseases to brain disorders is limited, and its genetic and biochemical associations remain unclear. Our aim is to examine the links between liver diseases and brain disorders. This prospective cohort study utilized data from 492 059 participants in the UK Biobank. We identified 508 cases of alcoholic liver disease (ALD), 583 cases of non-alcoholic fatty liver disease (NAFLD), and 557 cases of viral hepatitis (VH) based on International Classification of Diseases (ICD) codes. Initially, we employed multiple linear and logistic regression to assess associations between liver diseases, polygenic risk score (PRS), inflammatory and metabolic biomarkers, and brain function. Cox proportional hazard models were then applied to determine the impact of liver diseases on the incidence of brain disorders. Ultimately, structural equation models were used to explore potential genetic and biomarker pathways. During a median follow-up of 14.46 years, participants with ALD, NAFLD, and VH demonstrated poorer cognition, mental health, and motor function compared to the healthy group, with p < 0.05 for false discovery rate (FDR-Q < 0.05). They exhibited increased risks for dementia (hazard ratios [HRs]: 2.28-4.10; FDR-Q < 0.001), major depressive disorder (HRs: 2.25-3.23; FDR-Q < 0.001), and generalized anxiety disorder (HRs: 1.70-2.66; FDR-Q < 0.01). Additionally, C-reactive protein, neutrophil-to-lymphocyte ratio, platelets, and low-density lipoprotein lipid components mediated the associations between PRS, liver diseases, and brain disorders. Our findings demonstrated that liver diseases were risk factors for brain disorders, with genetic and biochemical associations contributing to these risks.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 59 participants. This cohort study found that people with alcoholic liver disease, non-alcoholic fatty liver disease, and viral hepatitis had poorer cognition and higher risks of dementia and other brain disorders. It suggests that liver diseases are risk factors for brain disorders, with genetic and biochemical factors contributing, but it does not show that treating liver disease prevents dementia.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Guo, H., Gao, P., Zhang, W., Fu, Y., Chi, H., Zhang, Z., et al. (2025). Liver Diseases and Brain Disorders: Genetic Mechanisms and Biomarker Pathways in a Prospective Cohort Study From the UK Biobank. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70066
Vancouver
Guo H, Gao P, Zhang W, Fu Y, Chi H, Zhang Z, et al. Liver Diseases and Brain Disorders: Genetic Mechanisms and Biomarker Pathways in a Prospective Cohort Study From the UK Biobank. Journal of Neurochemistry. 2025. doi:10.1111/jnc.70066. PMID: 40230026.
BibTeX
@article{guo2025-40230026,
author = {Guo, Hai‐Hua and Gao, Pei‐Yang and Zhang, Wei and Fu, Yan and Chi, Hao‐Chen and Zhang, Zi‐Hao and Han, Shuang‐Ling and Han, Baolin and others},
title = {{Liver Diseases and Brain Disorders: Genetic Mechanisms and Biomarker Pathways in a Prospective Cohort Study From the UK Biobank}},
journal = {Journal of Neurochemistry},
year = {2025},
doi = {10.1111/jnc.70066},
pmid = {40230026},
url = {https://doi.org/10.1111/jnc.70066}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- During a median follow-up of 14.46 years, participants with ALD, NAFLD, and VH demonstrated poorer cognition, mental health, and motor function compared to the healthy group, with p < 0.05 for false discovery rate (FDR-Q < 0.05).
- Our findings demonstrated that liver diseases were risk factors for brain disorders, with genetic and biochemical associations contributing to these risks.
Why it matters
This cohort study found that people with alcoholic liver disease, non-alcoholic fatty liver disease, and viral hepatitis had poorer cognition and higher risks of dementia and other brain disorders. It suggests that liver diseases are risk factors for brain disorders, with genetic and biochemical factors contributing, but it does not show that treating liver disease prevents dementia.
Study details
- Study designcohort study
- Participants59
- Evidence strengthModerate
How this study scored 54/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Neurochemistry) |
| Journal's citation record | 3 / 4 | Journal of Neurochemistry: journal h-index 349 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 1 / 4 | 59 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 5 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 3.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 5 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Hui-Fu Wang: h-index 52 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Fudan University: institution h-index 954 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 6 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40230026) |
| Free to read | 2 / 2 | Free to read |
| Total | 54 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1111/jnc.70066
- PubMed: 40230026
- Original source →
- Free full text: Journal of Neurochemistry →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Long-term cohort studies from nearby years
Also tagged “small”
900 studies in the library carry the topic tag “small”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 900 tagged studies.